Biotherapeutics
Jun 07, 2010 at 22:47 | Source: Reuters
Jul 10, 2009 at 19:27 | Source: press release
Oct 29, 2008 at 13:29
Sep 12, 2008 at 11:57
Oct 08, 2007 at 12:36
Photos »
/ 
Related News »
When Protalix BioTherapeutics (AMEX:PLX) reported earnings 17 days ago on May 9th, 2012, analysts, on average, expected the company to report a loss of $0.08 on sales of $1.2 million. Protalix BioTherapeutics actually reported a loss of $0.07 per share on ...
May 26, 2012 at 12:49 | Source: Financial News Network Online
BETHESDA, MD, May 17, 2012 -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio) announced today that it now has 41 clinical trial sites open and recruiting across the United States in its ongoing clinical trial of DCVax ®-L immune therapy for Glioblastoma ...
May 17, 2012 at 18:22 | Source: American Cancer Society
One of today's notable stocks on the rise is Protalix BioTherapeutics (AMEX:PLX), up 2.0% to $6.57. The S&P is trading higher by 0.9% to 1,328 and the Dow is trading 0.5% higher to 12,570. Protalix BioTherapeutics Inc. is a biotechnology company that has ...
May 22, 2012 at 14:55 | Source: Financial News Network Online
Jennerex Announces Data Presentations Relating to Oncolytic Virus JX-594 at American Society of Clin
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy ...
May 19, 2012 at 13:55 | Source: PR-USA.net
SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire via COMTEX/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer ...
May 17, 2012 at 01:33 | Source: TMCnet
first quarter of 2013, after which time Eleven will move directly into the pivotal trials it will need to complete to gain FDA approval. “We’ve had these discussions with the FDA already,” she says. “We’re so confident in the mechanism ...
May 8, 2012 at 11:52 | Source: Xconomy
May 15, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the highest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among ...
May 15, 2012 at 10:10 | Source: TMCnet
Cambridge biopharmaceutical company Eleven Biotherapeutics, Inc. said today it has secured $20 million in series A equity financing, expanding the total Series A investment to $45 million. New investor, JAFCO Co., Ltd. joined the Series A financing with a ...
May 8, 2012 at 14:22 | Source: Boston Herald
GE Healthcare Life Sciences has over 30 years' experience in developing technologies for the manufacture of biotherapeutics. The company also has a pioneering research program aimed at developing new technologies that will help enable the new ...
May 22, 2012 at 11:35 | Source: News-Medical.Net
Led locally by Hoag Memorial Hospital Presbyterian and Christopher Duma, MD, FACS, Program Director of Hoag Brain Tumor Program, the FDA-authorized, Phase II trial is sponsored by Northwest Biotherapeutics. The DCVax®-L personalized cancer ...
May 24, 2012 at 00:41 | Source: Orange County Register